{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:29:10Z","timestamp":1791959350497,"version":"4.3.4"},"reference-count":88,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Structural Biology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jsb.2025.108177","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T22:07:37Z","timestamp":1739311657000},"page":"108177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Computational identification of B and T-cell epitopes for designing a multi-epitope vaccine against SARS-CoV-2 spike glycoprotein"],"prefix":"10.1016","volume":"217","author":[{"given":"Truc Ly","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thong Ba","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heebal","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsb.2025.108177_b0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.jsb.2025.108177_b0010","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ijbiomac.2020.06.213","article-title":"Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach","volume":"162","author":"Ahammad","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"11","key":"10.1016\/j.jsb.2025.108177_b0015","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.3390\/v14112374","article-title":"Immunoinformatics-aided design of a peptide based multiepitope vaccine targeting glycoproteins and membrane proteins against monkeypox virus","volume":"14","author":"Akhtar","year":"2022","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.jsb.2025.108177_b0020","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3390\/vaccines11020364","article-title":"Secreted aspartyl proteinases targeted multi-epitope vaccine design for candida dubliniensis using immunoinformatics","volume":"11","author":"Akhtar","year":"2023","journal-title":"Vaccines"},{"issue":"8","key":"10.1016\/j.jsb.2025.108177_b0025","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nsmb1123","article-title":"Architecture of the SARS coronavirus prefusion spike","volume":"13","author":"Beniac","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"5","key":"10.1016\/j.jsb.2025.108177_b0030","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s12033-021-00432-6","article-title":"Bioengineering of novel non-replicating mRNA (NRM) and self-amplifying mRNA (SAM) vaccine candidates against SARS-CoV-2 using immunoinformatics approach","volume":"64","author":"Bhattacharya","year":"2022","journal-title":"Mol. Biotechnol."},{"issue":"10","key":"10.1016\/j.jsb.2025.108177_b0035","doi-asserted-by":"crossref","first-page":"e1003266","DOI":"10.1371\/journal.pcbi.1003266","article-title":"Properties of MHC class I presented peptides that enhance immunogenicity","volume":"9","author":"Calis","year":"2013","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.jsb.2025.108177_b0040","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.antiviral.2017.01.023","article-title":"Rational design and efficacy of a multi-epitope recombinant protein vaccine against foot-and-mouth disease virus serotype A in pigs","volume":"140","author":"Cao","year":"2017","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jsb.2025.108177_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.786144","article-title":"Frontiers | anti-CD40 antibody fused to CD40 ligand is a superagonist platform for adjuvant intrinsic DC-targeting vaccines","volume":"12","author":"Ceglia","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.jsb.2025.108177_b0050","doi-asserted-by":"crossref","DOI":"10.1002\/jmr.3007","article-title":"An immunoinformatics and structural vaccinology study to design a multi\u2010epitope vaccine against <i>Staphylococcus aureus<\/i> infection","volume":"36","author":"Chatterjee","year":"2023","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.jsb.2025.108177_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2023.1280273","article-title":"Immunoinformatics-aided rational design of a multi-epitope vaccine targeting feline infectious peritonitis virus","volume":"10","author":"Chawla","year":"2023","journal-title":"Front. Vet. Sci."},{"issue":"2","key":"10.1016\/j.jsb.2025.108177_b0060","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1021\/acs.jcim.1c01451","article-title":"Omicron variant (B.1.1.529): infectivity, vaccine breakthrough, and antibody resistance","volume":"62","author":"Chen","year":"2022","journal-title":"J. Chem. Inf. Model."},{"issue":"10","key":"10.1016\/j.jsb.2025.108177_b0065","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1002\/jmv.26234","article-title":"Emerging coronaviruses: genome structure, replication, and pathogenesis","volume":"92","author":"Chen","year":"2020","journal-title":"J. Med. Virol."},{"issue":"3","key":"10.1016\/j.jsb.2025.108177_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248061","article-title":"Immuno-informatics design of a multimeric epitope peptide based vaccine targeting SARS-CoV-2 spike glycoprotein","volume":"16","author":"Chukwudozie","year":"2021","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jsb.2025.108177_b0075","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1501118","article-title":"Vaccination produces CD4 T cells with a novel CD154\u2013CD40-dependent cytolytic mechanism","volume":"195","author":"Coler","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.jsb.2025.108177_b0080","doi-asserted-by":"crossref","first-page":"104742","DOI":"10.1016\/j.antiviral.2020.104742","article-title":"The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade","volume":"176","author":"Coutard","year":"2020","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jsb.2025.108177_b0085","article-title":"Identification of potential flavonoid compounds as antibacterial therapeutics against Klebsiella pneumoniae infection using structure-based virtual screening and molecular dynamics simulation","volume":"2023","author":"Dey","year":"2023","journal-title":"Mol. Divers."},{"issue":"4","key":"10.1016\/j.jsb.2025.108177_b0090","doi-asserted-by":"crossref","DOI":"10.1007\/s12026-023-09374-4","article-title":"Designing of multi-epitope peptide vaccine against Acinetobacter baumannii through combined immunoinformatics and protein interaction\u2013based approaches","volume":"71","author":"Dey","year":"2023","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jsb.2025.108177_b0095","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/263952","article-title":"Prediction of IL4 inducing peptides","volume":"2013","author":"Dhanda","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.jsb.2025.108177_b0100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1745-6150-8-30","article-title":"Designing of interferon-gamma inducing MHC class-II binders","volume":"8","author":"Dhanda","year":"2013","journal-title":"Biol. Direct"},{"issue":"6","key":"10.1016\/j.jsb.2025.108177_b0105","doi-asserted-by":"crossref","DOI":"10.1007\/s00894-014-2278-5","article-title":"AllerTOP vol 2\u2014a server for in silico prediction of allergens","volume":"20","author":"Dimitrov","year":"2014","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.jsb.2025.108177_b0110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinf."},{"issue":"3","key":"10.1016\/j.jsb.2025.108177_b0115","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrmicro2090","article-title":"The spike protein of SARS-CoV\u2013a target for vaccine and therapeutic development","volume":"7","author":"Du","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"issue":"8","key":"10.1016\/j.jsb.2025.108177_b0120","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1007\/s00253-013-5408-6","article-title":"Immunological features and efficacy of a multi-epitope vaccine CTB-UE against H. pylori in BALB\/c mice model","volume":"98","author":"Guo","year":"2013","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"9","key":"10.1016\/j.jsb.2025.108177_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073957","article-title":"In silico approach for predicting toxicity of peptides and proteins","volume":"8","author":"Gupta","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jsb.2025.108177_b0130","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jsb.2025.108177_b0135","series-title":"The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells","author":"Hoffmann","year":"2020"},{"issue":"4","key":"10.1016\/j.jsb.2025.108177_b0140","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/vim.2011.0099","article-title":"SARS-CoV regulates immune function-related gene expression in human monocytic cells","volume":"25","author":"Hu","year":"2012","journal-title":"Viral Immunol."},{"issue":"W1","key":"10.1016\/j.jsb.2025.108177_b0145","doi-asserted-by":"crossref","first-page":"W24","DOI":"10.1093\/nar\/gkx346","article-title":"BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes","volume":"45","author":"Jespersen","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"23","key":"10.1016\/j.jsb.2025.108177_b0150","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1016\/j.vaccine.2017.04.031","article-title":"Evaluation of tandem Chlamydia trachomatis MOMP multi-epitopes vaccine in BALB\/c mice model","volume":"35","author":"Jiang","year":"2017","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jsb.2025.108177_b0155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1747-0285.2009.00825.x","article-title":"Advantages of a synthetic peptide immunogen over a protein immunogen in the development of an anti-pilus vaccine for Pseudomonas aeruginosa","volume":"74","author":"Kao","year":"2009","journal-title":"Chem. Biol. Drug Des."},{"issue":"1","key":"10.1016\/j.jsb.2025.108177_b0160","doi-asserted-by":"crossref","first-page":"10895","DOI":"10.1038\/s41598-020-67749-1","article-title":"A candidate multi-epitope vaccine against SARS-CoV-2","volume":"10","author":"Kar","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jsb.2025.108177_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2020.09.025","article-title":"Infectious complications in patients treated with immune checkpoint inhibitors","volume":"141","author":"Karam","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jsb.2025.108177_b0170","doi-asserted-by":"crossref","DOI":"10.1021\/acsptsci.2c00130","article-title":"Immunoinformatics-aided design and <i>In Vivo<\/i> validation of a peptide-based multiepitope vaccine targeting canine circovirus","author":"Kaushik","year":"2022","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.jsb.2025.108177_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.865180","article-title":"Immunoinformatics aided design and in-vivo validation of a cross-reactive peptide based multi-epitope vaccine targeting multiple serotypes of dengue virus","volume":"13","author":"Kaushik","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.jsb.2025.108177_b0180","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/14760584.2019.1578216","article-title":"Immunological basis for enhanced immunity of nanoparticle vaccines","volume":"18","author":"Kelly","year":"2019","journal-title":"Expert Rev. Vaccines"},{"issue":"W1","key":"10.1016\/j.jsb.2025.108177_b0185","doi-asserted-by":"crossref","first-page":"W294","DOI":"10.1093\/nar\/gks493","article-title":"GalaxyWEB server for protein structure prediction and refinement","volume":"40","author":"Ko","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.jsb.2025.108177_b0190","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4049\/jimmunol.180.1.309","article-title":"Increased antigen presentation efficiency by coupling antigens to MHC class i trafficking signals","volume":"180","author":"Kreiter","year":"2007","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.jsb.2025.108177_b0195","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0022-2836(82)90515-0","article-title":"A simple method for displaying the hydropathic character of a protein","volume":"157","author":"Kyte","year":"1982","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.jsb.2025.108177_b0200","doi-asserted-by":"crossref","first-page":"105924","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges","volume":"55","author":"Lai","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jsb.2025.108177_b0205","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/1471-2105-8-424","article-title":"Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction","volume":"8","author":"Larsen","year":"2007","journal-title":"BMC Bioinf."},{"issue":"4","key":"10.1016\/j.jsb.2025.108177_b0210","doi-asserted-by":"crossref","DOI":"10.1007\/BF00228148","article-title":"AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR","volume":"8","author":"Laskowski","year":"1996","journal-title":"J. Biomol. NMR"},{"issue":"1","key":"10.1016\/j.jsb.2025.108177_b0215","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/pro.3289","article-title":"PDBsum: structural summaries of PDB entries","volume":"27","author":"Laskowski","year":"2018","journal-title":"Protein Science : a Publication of the Protein Society"},{"key":"10.1016\/j.jsb.2025.108177_b0220","doi-asserted-by":"crossref","first-page":"e6185","DOI":"10.7717\/peerj.6185","article-title":"Application of built-in adjuvants for epitope-based vaccines","volume":"6","author":"Lei","year":"2019","journal-title":"PeerJ"},{"issue":"4","key":"10.1016\/j.jsb.2025.108177_b0225","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00262-013-1516-5","article-title":"Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors","volume":"63","author":"Lennerz","year":"2014","journal-title":"Cancer Immunol. Immunother."},{"issue":"6","key":"10.1016\/j.jsb.2025.108177_b0230","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jmb.2013.11.024","article-title":"Toll-like receptors in antiviral innate immunity","volume":"426","author":"Lester","year":"2014","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.jsb.2025.108177_b0235","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/vaccines2030515","article-title":"Peptide vaccine: progress and challenges","volume":"2","author":"Li","year":"2014","journal-title":"Vaccines"},{"issue":"32","key":"10.1016\/j.jsb.2025.108177_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2008.05.018","article-title":"CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individuals","volume":"26","author":"Liu","year":"2008","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.jsb.2025.108177_b0245","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/bjh.14686","article-title":"A novel multi-epitope vaccine from MMSA-1 and DKK1 for multiple myeloma immunotherapy","volume":"178","author":"Lu","year":"2017","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.jsb.2025.108177_b0250","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bbrc.2020.03.047","article-title":"Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection","volume":"526","author":"Luan","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"W1","key":"10.1016\/j.jsb.2025.108177_b0255","doi-asserted-by":"crossref","first-page":"W636","DOI":"10.1093\/nar\/gkz268","article-title":"The EMBL-EBI search and sequence analysis tools APIs in 2019","volume":"47","author":"Madeira","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jsb.2025.108177_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2022.113325","article-title":"Immunoinformatics-guided designing of epitope-based subunit vaccine from Pilus assembly protein of Acinetobacter baumannii bacteria","volume":"508","author":"Mahapatra","year":"2022","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jsb.2025.108177_b0265","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3390\/pathogens12030376","article-title":"Designing a next-generation multiepitope-based vaccine against staphylococcus aureus using reverse vaccinology approaches","volume":"12","author":"Mahapatra","year":"2023","journal-title":"Pathogens"},{"issue":"12","key":"10.1016\/j.jsb.2025.108177_b0270","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2174\/1389201017666160914191106","article-title":"Harnessing bioinformatics for designing a novel multiepitope peptide vaccine against breast cancer","volume":"17","author":"Mahmoodi","year":"2016","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"1","key":"10.1016\/j.jsb.2025.108177_b0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170504","article-title":"Characterization of a broadly reactive anti-CD40 agonistic monoclonal antibody for potential use as an adjuvant","volume":"12","author":"Martin","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jsb.2025.108177_b0280","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.coi.2017.06.005","article-title":"Old and new adjuvants","volume":"47","author":"McKee","year":"2017","journal-title":"Curr. Opin. Immunol."},{"issue":"7","key":"10.1016\/j.jsb.2025.108177_b0285","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/nbt1215","article-title":"A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virus","volume":"24","author":"Moutaftsi","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jsb.2025.108177_b0290","doi-asserted-by":"crossref","first-page":"42851","DOI":"10.1038\/srep42851","article-title":"Computer-aided designing of immunosuppressive peptides based on IL-10 inducing potential","volume":"7","author":"Nagpal","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.jsb.2025.108177_b0295","doi-asserted-by":"crossref","DOI":"10.1172\/JCI44327","article-title":"A composite MyD88\/CD40 switch synergistically activates mouse and human dendritic cells for enhanced antitumor efficacy","volume":"121","author":"Narayanan","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.jsb.2025.108177_b0300","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3390\/biomedicines11041041","article-title":"Artificial intelligence assisted pharmacophore design for philadelphia chromosome-positive leukemia with gamma-tocotrienol: a toxicity comparison approach with asciminib","volume":"11","author":"Naveed","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jsb.2025.108177_b0305","first-page":"1","article-title":"Designing a multi-epitope candidate vaccine by employing immunoinformatics approaches to control African swine fever spread","author":"Nguyen","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.jsb.2025.108177_b0310","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.1038\/s41598-024-56554-9","article-title":"Immunoinformatics and computational approaches driven designing a novel vaccine candidate against Powassan virus","volume":"14","author":"Nguyen","year":"2024","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jsb.2025.108177_b0315","doi-asserted-by":"crossref","DOI":"10.1007\/s10989-022-10382-5","article-title":"Immunogenic epitope-based vaccine prediction from surface glycoprotein of MERS-CoV by deploying immunoinformatics approach","volume":"28","author":"Nguyen","year":"2022","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.jsb.2025.108177_b0320","doi-asserted-by":"crossref","DOI":"10.1002\/btpr.595","article-title":"Recombinant monomeric CD40 ligand for delivering polymer particles to dendritic cells","volume":"27","author":"Palumbo","year":"2011","journal-title":"Biotechnol. Prog."},{"issue":"12","key":"10.1016\/j.jsb.2025.108177_b0325","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1128\/CVI.00290-09","article-title":"Vaccines: the fourth century","volume":"16","author":"Plotkin","year":"2009","journal-title":"Clinical and Vaccine Immunology : CVI"},{"issue":"8","key":"10.1016\/j.jsb.2025.108177_b0330","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.166.8.5115","article-title":"CD40 signaling converts a minimally immunogenic antigen into a potent vaccine against the intracellular pathogen listeria monocytogenes","volume":"166","author":"Rolph","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.jsb.2025.108177_b0335","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.meegid.2017.04.009","article-title":"Development of a multi-epitope peptide vaccine inducing robust T cell responses against brucellosis using immunoinformatics based approaches","volume":"51","author":"Saadi","year":"2017","journal-title":"Infect. Genet. Evol."},{"issue":"5","key":"10.1016\/j.jsb.2025.108177_b0340","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s12033-021-00303-0","article-title":"Bioinformatics analysis of SARS-CoV-2 to approach an effective vaccine candidate against COVID-19","volume":"63","author":"Sadat","year":"2021","journal-title":"Mol. Biotechnol."},{"issue":"3","key":"10.1016\/j.jsb.2025.108177_b0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264700","article-title":"Epitope-based peptide vaccine design and elucidation of novel compounds against 3C like protein of SARS-CoV-2","volume":"17","author":"Sajid","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jsb.2025.108177_b0350","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/ATVBAHA.120.315229","article-title":"ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Serine Protease 2) expression and localization of SARS-CoV-2 infection in the human heart","volume":"41","author":"Sakamoto","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"D1","key":"10.1016\/j.jsb.2025.108177_b0355","doi-asserted-by":"crossref","first-page":"D92","DOI":"10.1093\/nar\/gkaa1023","article-title":"GenBank","volume":"49","author":"Sayers","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"15","key":"10.1016\/j.jsb.2025.108177_b0360","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1158\/1078-0432.CCR-13-0002","article-title":"A randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602)","volume":"19","author":"Slingluff","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.jsb.2025.108177_b0365","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13073-021-00910-1","article-title":"Landscape and selection of vaccine epitopes in SARS-CoV-2","volume":"13","author":"Smith","year":"2021","journal-title":"Genome Med."},{"issue":"1","key":"10.1016\/j.jsb.2025.108177_b0370","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/pharmaceutics8010007","article-title":"Liposome-based adjuvants for subunit vaccines: formulation strategies for subunit antigens and immunostimulators","volume":"8","author":"Tandrup Schmidt","year":"2016","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jsb.2025.108177_b0375","doi-asserted-by":"crossref","unstructured":"TheUniProtConsortium, UniProt: the universal protein knowledgebase. Nucleic acids research, 2017. 45(D1): p. D158-D169.","DOI":"10.1093\/nar\/gkw1099"},{"key":"10.1016\/j.jsb.2025.108177_b0380","unstructured":"Thermostability and Aliphatic Index of Globular Proteins. The Journal of Biochemistry, 1980."},{"issue":"30","key":"10.1016\/j.jsb.2025.108177_b0385","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1016\/S0264-410X(01)00111-6","article-title":"A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers","volume":"19","author":"Toledo","year":"2001","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.jsb.2025.108177_b0390","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00638-15","article-title":"Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection","volume":"6","author":"Totura","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.jsb.2025.108177_b0395","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3389\/fimmu.2014.00316","article-title":"A comparative review of toll-like receptor 4 expression and functionality in different animal species","volume":"5","author":"Vaure","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jsb.2025.108177_b0400","series-title":"Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein","author":"Walls","year":"2020"},{"key":"10.1016\/j.jsb.2025.108177_b0405","unstructured":"WHO. Number of COVID-19 cases reported to WHO (cumulative total). 2024 [cited 2024 15 September]; Available from: https:\/\/data.who.int\/dashboards\/covid19\/cases?n=c."},{"key":"10.1016\/j.jsb.2025.108177_b0410","series-title":"Reduced neutralization of SARS-CoV-2 omicron variant by vaccine sera and monoclonal antibodies","author":"Wilhelm","year":"2021"},{"key":"10.1016\/j.jsb.2025.108177_b0415","series-title":"2-D Proteome Analysis Protocols","first-page":"531","article-title":"Protein identification and analysis tools in the ExPASy server","author":"Wilkins","year":"1999"},{"issue":"W1","key":"10.1016\/j.jsb.2025.108177_b0420","doi-asserted-by":"crossref","first-page":"W174","DOI":"10.1093\/nar\/gkv342","article-title":"I-TASSER server: new development for protein structure and function predictions","volume":"43","author":"Yang","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.jsb.2025.108177_b0425","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s40203-023-00156-2","article-title":"Development of conserved multi-epitopes based hybrid vaccine against SARS-CoV-2 variants: an immunoinformatic approach","volume":"11","author":"Yaseen","year":"2023","journal-title":"In Silico Pharmacol."},{"issue":"36","key":"10.1016\/j.jsb.2025.108177_b0430","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1016\/j.vaccine.2009.05.009","article-title":"Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB\/c mice model","volume":"27","author":"Zhou","year":"2009","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.jsb.2025.108177_b0435","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1007\/s00253-014-5517-x","article-title":"Hepatitis B virus surface antigen as delivery vector can enhance Chlamydia trachomatis MOMP multi-epitope immune response in mice","volume":"98","author":"Zhu","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"8","key":"10.1016\/j.jsb.2025.108177_b0440","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106060","article-title":"Agonistic anti-CD40 enhances the CD8+ T cell response during vesicular stomatitis virus infection","volume":"9","author":"Zickovich","year":"2014","journal-title":"PLoS One"}],"container-title":["Journal of Structural Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047847725000127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047847725000127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T06:24:59Z","timestamp":1749018299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047847725000127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":88,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1047847725000127"],"URL":"https:\/\/doi.org\/10.1016\/j.jsb.2025.108177","relation":{},"ISSN":["1047-8477"],"issn-type":[{"value":"1047-8477","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computational identification of B and T-cell epitopes for designing a multi-epitope vaccine against SARS-CoV-2 spike glycoprotein","name":"articletitle","label":"Article Title"},{"value":"Journal of Structural Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsb.2025.108177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108177"}}